Published in Biomark Insights on January 28, 2010
Identification of miRNA-103 in the cellular fraction of human peripheral blood as a potential biomarker for malignant mesothelioma--a pilot study. PLoS One (2012) 0.97
Development of an enzyme-linked immunosorbent assay for the detection of human calretinin in plasma and serum of mesothelioma patients. BMC Cancer (2010) 0.84
Changes of mesothelin and osteopontin levels over time in formerly asbestos-exposed power industry workers. Int Arch Occup Environ Health (2013) 0.83
Bioanalytical techniques for detecting biomarkers of response to human asbestos exposure. Bioanalysis (2015) 0.81
Association of biomarker levels with severity of asbestos-related diseases. Saf Health Work (2012) 0.77
Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J Clin Oncol (2003) 11.22
The European mesothelioma epidemic. Br J Cancer (1999) 6.28
Mesothelin-family proteins and diagnosis of mesothelioma. Lancet (2003) 2.98
Malignant mesothelioma 1982: review of 4710 published cases. Br J Dis Chest (1983) 2.36
Soluble mesothelin-related protein in an asbestos-exposed population: the dust diseases board cohort study. Am J Respir Crit Care Med (2008) 2.21
Diagnostic value of CYFRA 21-1 tumor marker and CEA in pleural effusion due to mesothelioma. Chest (2001) 1.71
Mesothelin family proteins and diagnosis of mesothelioma: analytical evaluation of an automated immunoassay and preliminary clinical results. Clin Chem Lab Med (2007) 1.52
Effects of personal characteristics on serum CA125, mesothelin, and HE4 levels in healthy postmenopausal women at high-risk for ovarian cancer. Cancer Epidemiol Biomarkers Prev (2008) 1.52
Utility of osteopontin and serum mesothelin in malignant pleural mesothelioma diagnosis and prognosis assessment. Clin Cancer Res (2007) 1.45
Effects of blood collection conditions on ovarian cancer serum markers. PLoS One (2007) 1.27
MESOMARK: a potential test for malignant pleural mesothelioma. Clin Chem (2007) 1.27
Soluble mesothelin-related peptide level elevation in mesothelioma serum and pleural effusions. Ann Thorac Surg (2008) 1.26
Clinical significance of serum mesothelin in patients with mesothelioma and lung cancer. Clin Cancer Res (2007) 1.24
Combined CA125 and mesothelin levels for the diagnosis of malignant mesothelioma. Chest (2007) 1.20
Inherent biological variation and reference values. Clin Chem Lab Med (2004) 1.09
Biomarkers for mesothelioma. Curr Opin Pulm Med (2007) 1.02
CA 125 and its relation to cardiac function. Am Heart J (1999) 1.00
Mesothelin-related predictive and prognostic factors in malignant mesothelioma: a nested case-control study. Lung Cancer (2008) 0.94
Effect of freeze-thaw cycles on serum measurements of AFP, CEA, CA125 and CA19-9. Scand J Clin Lab Invest (2007) 0.93
Serum levels of soluble mesothelin-related peptides in malignant and nonmalignant asbestos-related pleural disease: relation with past asbestos exposure. Cancer Epidemiol Biomarkers Prev (2009) 0.91
Levels of 8-hydroxy-2'-deoxyguanosine in DNA of white blood cells from workers highly exposed to asbestos in Germany. Mutat Res (2000) 0.87
Use of tumor markers for differential diagnosis of mesothelioma and secondary pleural malignancies. Clin Biochem (2000) 0.86
Renal function and serum concentration of five tumor markers (TATI, SCC, CYFRA 21-1, TPA, and TPS) in patients without evidence of neoplasia. Cancer Detect Prev (2000) 0.84
Soluble mesothelin-related peptides (SMRP) - high stability of a potential tumor marker for mesothelioma. Cancer Biomark (2007) 0.83
Glomerular filtration rate is a confounder for the measurement of soluble mesothelin in serum. Clin Chem (2009) 0.81
Large-scale genotyping identifies 41 new loci associated with breast cancer risk. Nat Genet (2013) 8.24
Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies. J Natl Cancer Inst (2010) 4.54
Threshold value estimation for respirable quartz dust exposure and silicosis incidence among workers in the german porcelain industry. J Occup Environ Med (2013) 4.47
Exposure to diesel motor exhaust and lung cancer risk in a pooled analysis from case-control studies in Europe and Canada. Am J Respir Crit Care Med (2010) 4.35
Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nat Genet (2013) 4.35
Modeling inherited metabolic disorders of the liver using human induced pluripotent stem cells. J Clin Invest (2010) 3.91
Genome-wide association analysis identifies three new breast cancer susceptibility loci. Nat Genet (2012) 3.20
Generation of functional hepatocytes from human embryonic stem cells under chemically defined conditions that recapitulate liver development. Hepatology (2010) 3.16
Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium. Hum Mol Genet (2011) 2.72
Early cell fate decisions of human embryonic stem cells and mouse epiblast stem cells are controlled by the same signalling pathways. PLoS One (2009) 2.18
Occupational exposure of air crews to tricresyl phosphate isomers and organophosphate flame retardants after fume events. Arch Toxicol (2012) 2.02
N-acetyltransferase 2 phenotype, occupation, and bladder cancer risk: results from the EPIC cohort. Cancer Epidemiol Biomarkers Prev (2013) 2.01
Signaling pathways controlling pluripotency and early cell fate decisions of human induced pluripotent stem cells. Stem Cells (2009) 1.96
A randomized trial of colpopexy and urinary reduction efforts (CARE): design and methods. Control Clin Trials (2003) 1.93
Occupational endotoxin-exposure and possible health effects on humans. Am J Ind Med (2006) 1.87
Cigarette smoking and lung cancer--relative risk estimates for the major histological types from a pooled analysis of case-control studies. Int J Cancer (2011) 1.74
Assessing exposure to phthalates - the human biomonitoring approach. Mol Nutr Food Res (2011) 1.70
Considerations of circadian impact for defining 'shift work' in cancer studies: IARC Working Group Report. Occup Environ Med (2010) 1.60
Associations of common variants at 1p11.2 and 14q24.1 (RAD51L1) with breast cancer risk and heterogeneity by tumor subtype: findings from the Breast Cancer Association Consortium. Hum Mol Genet (2011) 1.56
Bisphenol A in 24 h urine and plasma samples of the German Environmental Specimen Bank from 1995 to 2009: a retrospective exposure evaluation. J Expo Sci Environ Epidemiol (2012) 1.56
Evidence of gene-environment interactions between common breast cancer susceptibility loci and established environmental risk factors. PLoS Genet (2013) 1.56
Identifying sources of phthalate exposure with human biomonitoring: results of a 48h fasting study with urine collection and personal activity patterns. Int J Hyg Environ Health (2013) 1.56
Assessing interactions between the associations of common genetic susceptibility variants, reproductive history and body mass index with breast cancer risk in the breast cancer association consortium: a combined case-control study. Breast Cancer Res (2010) 1.51
Liver regeneration and recanalization time course following reversible portal vein embolization. J Hepatol (2008) 1.49
The role of haematuria in bladder cancer screening among men with former occupational exposure to aromatic amines. BJU Int (2011) 1.49
Epidemiology, implications and mechanisms underlying drug-induced weight gain in psychiatric patients. J Psychiatr Res (2003) 1.47
Increased engraftment of hepatic progenitors after activation of the hepatocyte growth factor signaling pathway by protein transduction. Exp Biol Med (Maywood) (2009) 1.40
Internal exposure to carcinogenic polycyclic aromatic hydrocarbons and DNA damage: a null result in brief. Arch Toxicol (2012) 1.40
No association of polymorphisms in the cell polarity gene SCRIB with breast cancer risk. Breast Cancer Res Treat (2010) 1.39
Fine-scale mapping of the FGFR2 breast cancer risk locus: putative functional variants differentially bind FOXA1 and E2F1. Am J Hum Genet (2013) 1.39
Sexual function 6 months after first delivery. Obstet Gynecol (2008) 1.39
Variation of the N-acetyltransferase 2 gene in a Romanian and a Kyrgyz population. Cancer Epidemiol Biomarkers Prev (2006) 1.38
Association of a common AKAP9 variant with breast cancer risk: a collaborative analysis. J Natl Cancer Inst (2008) 1.36
Small pulmonary nodules: effect of two computer-aided detection systems on radiologist performance. Radiology (2006) 1.34
Improving the techniques for human hepatocyte transplantation: report from a consensus meeting in London. Cell Transplant (2012) 1.31
Alteration of the pulmonary surfactant system in full-term infants with hereditary ABCA3 deficiency. Am J Respir Crit Care Med (2006) 1.30
Occupational exposure to inhalable wood dust in the member states of the European Union. Ann Occup Hyg (2006) 1.29
A novel murine model to deplete hepatic stellate cells uncovers their role in amplifying liver damage in mice. Hepatology (2013) 1.27
11q13 is a susceptibility locus for hormone receptor positive breast cancer. Hum Mutat (2012) 1.26
Longitudinal evidence for the association between work-related physical exposures and neck and/or shoulder complaints: a systematic review. Int Arch Occup Environ Health (2011) 1.26
Effects of clozapine and olanzapine on cytokine systems are closely linked to weight gain and drug-induced fever. Psychoneuroendocrinology (2008) 1.26
The incremental effect of psychosocial workplace factors on the development of neck and shoulder disorders: a systematic review of longitudinal studies. Int Arch Occup Environ Health (2013) 1.24
The CASP8 -652 6N del promoter polymorphism and breast cancer risk: a multicenter study. Breast Cancer Res Treat (2007) 1.24
Outcomes following vaginal prolapse repair and mid urethral sling (OPUS) trial--design and methods. Clin Trials (2009) 1.24
Psychosocial work stressors as antecedents of musculoskeletal problems: a systematic review and meta-analysis of stability-adjusted longitudinal studies. Soc Sci Med (2012) 1.23
Diurnal variations of interleukin-6 plasma levels are confounded by blood drawing procedures. Psychoneuroendocrinology (2002) 1.23
Renal cell cancer risk and occupational exposure to trichloroethylene: results of a consecutive case-control study in Arnsberg, Germany. Am J Ind Med (2003) 1.22
Night work and breast cancer - results from the German GENICA study. Scand J Work Environ Health (2009) 1.21
ERCC2 genotypes and a corresponding haplotype are linked with breast cancer risk in a German population. Cancer Epidemiol Biomarkers Prev (2004) 1.14
Operations and pelvic muscle training in the management of apical support loss (OPTIMAL) trial: design and methods. Contemp Clin Trials (2008) 1.14
Association between arsenic exposure from a coal-burning power plant and urinary arsenic concentrations in Prievidza District, Slovakia. Environ Health Perspect (2003) 1.14
Exposure to inhalable, respirable, and ultrafine particles in welding fume. Ann Occup Hyg (2012) 1.13
Chronic cholangitis caused by Bordetella hinzii in a liver transplant recipient. J Clin Microbiol (2004) 1.11
Cerebral amyloid-β proteostasis is regulated by the membrane transport protein ABCC1 in mice. J Clin Invest (2011) 1.10
Exposure assessment in epidemiological studies: what has to be considered when comparing job-exposure matrices? Occup Environ Med (2012) 1.09
Generation of functional cholangiocyte-like cells from human pluripotent stem cells and HepaRG cells. Hepatology (2014) 1.09
VHL mutations in renal cell cancer: does occupational exposure to trichloroethylene make a difference? Toxicol Lett (2004) 1.08
Clozapine and olanzapine are associated with food craving and binge eating: results from a randomized double-blind study. J Clin Psychopharmacol (2007) 1.07
Medicolegal assessment of the ability to drive a motor vehicle in persons with epilepsy. Dtsch Arztebl Int (2010) 1.07
Clinically significant lung function impairment due to current levels of respirable quartz? Occup Environ Med (2013) 1.07
Markers of genetic susceptibility in human environmental hygiene and toxicology: the role of selected CYP, NAT and GST genes. Int J Hyg Environ Health (2003) 1.06
Analysing the causes of chronic cough: relation to diesel exhaust, ozone, nitrogen oxides, sulphur oxides and other environmental factors. J Occup Med Toxicol (2006) 1.06
One-carbon metabolism and breast cancer risk: no association of MTHFR, MTR, and TYMS polymorphisms in the GENICA study from Germany. Cancer Epidemiol Biomarkers Prev (2005) 1.05
Assessment of mRNA and microRNA Stabilization in Peripheral Human Blood for Multicenter Studies and Biobanks. Biomark Insights (2010) 1.05
Evaluation of long noncoding RNA MALAT1 as a candidate blood-based biomarker for the diagnosis of non-small cell lung cancer. BMC Res Notes (2013) 1.04
Factors modifying the association between hormone-replacement therapy and breast cancer risk. Eur J Epidemiol (2005) 1.04
Is previous respiratory disease a risk factor for lung cancer? Am J Respir Crit Care Med (2014) 1.04
Breast cancer: a candidate gene approach across the estrogen metabolic pathway. Breast Cancer Res Treat (2007) 1.04
Nuclear matrix protein-22: a prospective evaluation in a population at risk for bladder cancer. Results from the UroScreen study. BJU Int (2012) 1.04
Repopulation of athymic mouse liver by cryopreserved early human fetal hepatoblasts. Hum Gene Ther (2004) 1.03
Breast cancer risk reduction and membrane-bound catechol O-methyltransferase genetic polymorphisms. Cancer Res (2008) 1.02
Common variants in the UBC9 gene encoding the SUMO-conjugating enzyme are associated with breast tumor grade. Int J Cancer (2009) 1.02
Results of renal transplantation using kidneys harvested from living donors at the University of Heidelberg. Nephrol Dial Transplant (2004) 1.02
Sclerosing pseudovascular rhabdomyosarcoma-immunohistochemical, ultrastructural, and genetic findings indicating a distinct subtype of rhabdomyosarcoma. Virchows Arch (2006) 1.02
Involvement of cathepsin H in the processing of the hydrophobic surfactant-associated protein C in type II pneumocytes. Am J Respir Cell Mol Biol (2002) 1.02
Focal progression in patients with gastrointestinal stromal tumors after initial response to imatinib mesylate: a three-center-based study of 38 patients. Gastric Cancer (2007) 1.01
Establishment of immortalized human hepatic stellate scavenger cells to develop bioartificial livers. Transplantation (2003) 1.01